Septic shock: Potential for modification

Clinical Pulmonary Medicine

Volumn 3, Issue 3, 1996, Pages 150-156

  Lorente, José A ^a   Landín, Luis ^b  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Immunotherapy; Intramucosal pH; Nitric oxide; Oxygen transport; Septic shock

Indexed keywords

ARGININE; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; CENTOXIN; EDOBACOMAB; ENDOTOXIN; HEMOGLOBIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LIPID A DERIVATIVE; N(G) METHYLARGININE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; POLYCLONAL ANTIBODY; POLYMYXIN B; RECOMBINANT TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; BACTERICIDAL ACTIVITY; CLINICAL TRIAL; CRITICAL ILLNESS; GRAM NEGATIVE INFECTION; HEMODYNAMIC MONITORING; HUMAN; IMMUNOMODULATION; INFLAMMATION; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; MEDIATOR RELEASE; NONHUMAN; SEPTIC SHOCK; STOMACH PH;

EID: 0030011281     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045413-199605000-00005     Document Type: Article

References (4)

1. Natanson C, Huffman WD, Suffredini AF, Eichacker PQ, Danner RL. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 1994;120:771-83.
2. Natanson C, Eichenholz PW, Danner RL, et al. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 1989;169:823-32.
3. Suffredini AF, Fromm RE, Parker MM, et al. The cardiovascular response of normal humans to administration of endotoxin. N Engl J Med 1989;321:280-7.
4. Greisman SE, Hornick RB, Wagner HN Jr., Woodward WE, Woodward TE. The role of endotoxin during typhoid fever and tularemia in man. IV. The integrity of the endotoxin tolerance mechanisms during infection. J Clin Invest 1969;48:613-29.